Burnham Asset Management’s AstraZeneca AZN Stock Holding History

Burnham Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,100	Closed	-$346K	–	204
2016 Q1	$346K	Sell	6,100 -300	-5%	-$18K	0.11%	164
2015 Q4	$435K	Buy	6,400 +300	+5%	+$19.7K	0.12%	153
2015 Q3	$388K	Sell	6,100 -200	-3%	-$13.2K	0.1%	163
2015 Q2	$401K	Hold	6,300	–	–	0.09%	174
2015 Q1	$431K	Sell	6,300 -100	-2%	-$6.95K	0.1%	172
2014 Q4	$450K	Buy	+6,400	New	+$458K	0.1%	170

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Burnham Asset Management's AZN Position: Q2 2016 in Review

Burnham Asset Management sold out of AstraZeneca (AZN) in Q2 2016, closing a stake of 6,100 shares — an estimated $346K sold.

Burnham Asset Management first reported a position in AZN in Q4 2014 and held it in 6 quarters. The position peaked at $450K in Q4 2014. 397 funds tracked by Wall St. Rank hold AZN as of Q2 2016.

Burnham Asset Management reported no remaining AstraZeneca position as of Q2 2016 after selling out during the quarter.
Burnham Asset Management sold 6,100 AstraZeneca shares in Q2 2016, an estimated $346K.
Burnham Asset Management first reported a position in AstraZeneca in Q4 2014 and held it in 6 quarters.
Burnham Asset Management's AstraZeneca position peaked at $450K in Q4 2014.
397 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.